Abstract
Breynia spp. are a key source of sulfur-containing spiroketal glycosides with potential anti-inflammatory activity. In this study, three new sulfur-containing spiroketals – breynin J (1), epibreynin J (2), and probreynogenin (3) – along with four known compounds – probreynin I (4), phyllaemblic acid (5), breynin B (6), and epibreynin B (7) – were isolated from the roots of Breynia disticha. The structures of compounds 1–7 were elucidated by extensive 1D and 2D NMR spectroscopic analyses, including 1D total correlation spectroscopy (TOCSY), HSQC, HMBC, double quantum-filtered (DQF)-COSY, heteronuclear two-bond correlation (H2BC), and HSQC-TOCSY experiments, as well as high-resolution electrospray ionization HRESIMS analysis, and quantum chemical electronic CD calculations. Furthermore, the absolute configurations of sugar residues were determined by derivatization of the hydrolysates with ʟ-cysteine methyl ester and o-tolyl isothiocyanate followed by HPLC analysis. The anti-inflammatory effects of the isolated compounds were evaluated based on the mRNA levels of proinflammatory cytokines in lipopolysaccharide (LPS)-stimulated RAW 264.7 murine macrophage cells. Compounds 1, 2, 6, and 7 inhibited the increase in interleukin (IL)-1β and IL-6 mRNA levels stimulated by LPS. Moreover, the most potent compound 7 was found to significantly inhibit the production of IL-1β and IL-6 proteins, as revealed by the analysis of culture supernatants.
Introduction
Breynia disticha J.R.Forst. & G.Forst. (Phyllanthaceae), commonly known as snow bush, is a tropical shrub native to New Caledonia and Vanuatu in the Western Pacific but has been naturalized in many regions globally. Investigations of the phytochemical compositions of several Breynia spp. have revealed sulfur-containing spiroketal glycosides [1-3], flavan-3-ol glycosides [4], alkaloids [5], and phenolic glycosides [5,6]. Notably, sulfur-containing spiroketal glycosides, represented by breynins and epibreynins, have characteristic sesquiterpenoid-derived structures. The sesquiterpenoid phyllaemblic acid and its glycosides, which are predicted to be biosynthetic precursors of breynins and epibreynins, have been isolated from several species of the genera Phyllanthus and Glochidion (both Phyllanthaceae) [7-10]. Nonetheless, to date, sulfur-containing derivatives have only been identified in the genus Breynia.
Breynia spp. have traditionally been used as anti-inflammatory medicines for intestinal and stomach inflammation, asthma, eczema, meningitis, and sore throat [11]. Furthermore, epibreynin D, a major sulfur-containing spiroketal in Breynia fruticosa, has been reported to have anti-arthritis activity against complete Freund's adjuvant-induced arthritis in rats [12]. However, the molecular mechanisms of these anti-inflammatory effects have not been investigated.
In our ongoing search for bioactive natural products, we have isolated three new spiroketals – breynin J (1), epibreynin J (2), and probreynogenin (3) – and four known spiroketals – probreynin I (4) [13], phyllaemblic acid (5) [10], breynin B (6) [2], and epibreynin B (7) [2] – from the roots of B. disticha, a species that has not previously been chemically investigated (Figure 1). Herein, we describe the isolation and structural elucidation of new compounds 1–3 and known spiroketal 4, which has not been fully characterized in previous reports [13]. Furthermore, the anti-inflammatory effects of compounds 1–3, 6, and 7 are evaluated using RAW 264.7 murine macrophage cells.
Results and Discussion
B. disticha roots were extracted with methanol (MeOH), and the extract suspended in water was sequentially partitioned with ethyl acetate and n-butanol. Breynin J (1), epibreynin J (2), and probreynin I (4) together with known compounds 6 and 7 were isolated from the n-butanol fraction (Figure 1). Probreynogenin (3) and known compound 5 were obtained from the ethyl acetate fraction (Figure 1). The structures of known compounds 5–7 were identified based on 1H and 13C NMR data [2,3,10].
Breynin J (1) was isolated as an amorphous, colorless powder. The HRESIMS spectrum exhibited a sodium adduct ion peak at m/z 1107.3177, consistent with a molecular formula of C45H64O28SNa (calcd 1107.3197). The IR spectrum showed absorption peaks corresponding to hydroxy groups (νmax = 3414 cm−1) and carbonyl groups (νmax = 1782 and 1695 cm−1). The 1H NMR signals (Table 1) were characteristic of a breynogenin moiety, namely, a methyl group [δH 0.92 (d, J = 6.9 Hz, 3H, H3-18)], four methylene groups [δH 3.42 (br d, J = 15.6 Hz, 1H, H-2a), 3.70 (dd, J = 4.5, 15.6 Hz, 1H, H-2b), 1.70 (br d, J = 13.7 Hz, 1H, H-5α), 1.25 (t, J = 13.7 Hz, 1H, H-5β); 2.12 (d, J = 3.7 Hz, 2H, H2-10); and 3.97 (t, J = 10.5 Hz, 1H, H-13α), 3.65 (1H, m, H-13β)], and seven sp3 methines. In addition, signals corresponding to a p-hydroxybenzoate group [δH 8.02 (d, J = 8.9 Hz, 2H, H-21, 25), 6.94 (d, J = 8.9 Hz, 2H, H-22, 24)] were observed. The 13C NMR spectrum (Table 1) suggested the presence of a breynogenin-α-S-oxide moiety, similar to that in breynins B, D, G, and I [2], with the observed resonances including a carbonyl group [δC 212.3 (C-8)], a spiroketal center [δC 100.6 (C-9)], and a p-hydroxybenzoate [δC 167.6 (C-19), 122.7 (C-20), 133.2 (C-21, 25), 116.7 (C-22, 24), 163.4 (C-23)]. The presence of a breynogenin-α-S-oxide moiety was further evidenced by HSQC, HMBC, and double quantum filtered (DQF)-COSY correlations (Figure 2). The spin–spin coupling constants (SSCCs) in the 1H NMR spectrum and the rotating-frame Overhauser effects (ROEs) between H-2β/H-3, H-2β/H-5β, H-3/H-4, H-3/5β, H-4/H-5α, H-4/H-17, H-5α/H-6, H-5β/H-6, H-11/H-12, H-12/H-13β, H-16/H-22(24), and H-17/H-21(25) in 1D and 2D ROE spectroscopy (ROESY) suggested that the relative configuration of the aglycone in 1 is identical to that in breynin B (6).
Table 1: 1H and 13C NMR data for the aglycone moieties of 1–4.a
no. | 1 | 2 | 3 | 4 | |||||||
δC | δH (mult, J) | δC | δH (mult, J) | δC | δH (mult, J) | δC | δH (mult, J) | ||||
2 | 56.2 | 3.42 (br d, 15.6) | 61.7 | 4.46 (d, 14.6) | 37.3 | 3.32 (d, 15.6) | 36.96 | 3.24 (d, 16.0) | |||
3.70 (dd, 4.5, 15.6) | 3.10 (dd, 4.1, 15.1) | 3.44 (d, 15.6) | 3.64 (d, 16.0) | ||||||||
3 | 87.7 | 4.53 (br d, 4.5) | 87.4 | 4.73 (d, 4.1) | 175.0 | 174.7 | |||||
4 | 38.7 | 3.10 (br d, 13.7) | 39.9 | 3.15 (m) | 36.6 | 3.28 (ddd, 3.1, 5.5, 14.9) | 37.03 | 3.37 (br d, 12.4) | |||
5 | 28.9 | 1.70 (br d, 13.7) | 28.4 | 1.87 (m) | 28.3 | 1.88 (dt, 2.3, 13.7) | 27.4 | 1.85 (br d, 14.6) | |||
1.25 (t, 13.7) | 1.80 (br t, 13.0) | 1.98 (m) | 2.07 (br t, 13.0) | ||||||||
6 | 70.3 | 3.94 (br s) | 71.5 | 3.94 (m) | 71.7 | 3.90 (br s) | 71.3 | 3.92 (br s) | |||
7 | 75.2 | 73.3 | 76.3 | 76.0 | |||||||
8 | 212.3 | 209.9 | 213.3 | 212.9 | |||||||
9 | 100.6 | 101.1 | 100.6 | 100.7 | |||||||
10 | 32.5 | 2.12 (d, 3.7) | 32.6 | 2.13 (d, 3.2) | 32.7 | 1.98 (m) | 33.0 | 2.00 (dd, 2.7, 14.6) | |||
2.23 (dd, 3.2, 15.4) | 2.18 (dd, 3.2, 15.1) | ||||||||||
11 | 69.8 | 5.44 (m) | 69.8 | 5.42 (q, 3.2) | 70.3 | 5.28 (q, 3.2) | 70.0b | 5.31 (br s) | |||
12 | 34.3 | 2.19 (m) | 34.2 | 2.20 (m) | 34.3 | 2.15 (m) | 34.5 | 2.13 (m) | |||
13 | 64.1 | 3.97 (t, 10.5) | 64.0 | 4.06 (t, 11.0) | 63.5 | 4.04 (t, 11.0) | 63.5 | 4.08 (t, 11.4) | |||
3.65 (m) | 3.69 (m) | 3.57 (dd, 4.6, 11.4) | 3.58 (d, 5.5, 12.4) | ||||||||
16 | 74.9 | 4.89 (m) | 74.4 | 4.90 (m) | 79.9 | 4.52 (t, 1.8) | 80.2 | 4.60 (t, 1.4) | |||
17 | 71.3 | 3.99 (d, 5.5) | 62.3 | 3.95 (m) | 46.1 | 3.73 (t, 2.3) | 45.3 | 3.74 (br s) | |||
18 | 12.9 | 0.92 (d, 6.9) | 12.9 | 0.91 (d, 6.9) | 13.1 | 0.88 (d, 6.9) | 13.2 | 0.85 (d, 6.9) | |||
19 | 167.6 | 167.5 | 168.1 | 167.6 | |||||||
20 | 122.7 | 122.8 | 122.8 | 123.0 | |||||||
21, 25 | 133.2 | 8.02 (d, 8.9) | 133.3 | 8.01 (d, 8.7) | 133.0 | 7.99 (d, 8.7) | 133.4 | 8.07 (d, 8.9) | |||
22, 24 | 116.7 | 6.94 (d, 8.9) | 116.5 | 6.88 (d, 8.7) | 116.4 | 6.90 (d, 8.7) | 116.9 | 6.98 (d, 8.9) | |||
23 | 163.4 | 163.4 | 163.4 | 163.2 | |||||||
COOH | 177.1 | 172.6 |
a1H and 13C NMR data were obtained at 400 and 100 MHz, respectively. All spectra were measured in CD3OD (δ in ppm, J in Hz). Overlapped signals were assigned based on the DQF-COSY, HSQC, HMBC, 1D-TOCSY, H2BC, and HSQC-TOCSY. bOverlapping signals with C-4′′ of the sugar moiety.
The remaining NMR resonances (Table 2) were attributed to a tetrasaccharide based on the observation of four anomeric methine signals at δC 103.2 (C-1′), 104.5 (C-1′′), 103.3 (C-1′′′), and 111.9 (C-1′′′′). Because the complex overlap of the glycosyl group signals complicated the HSQC, HMBC, and DQF-COSY analyses, 1D total correlation spectroscopy (TOCSY), HSQC-TOCSY, and heteronuclear two-bond correlation (H2BC) experiments were also performed (Figure 2) [14,15]. The HSQC-TOCSY spectrum showed two correlation series corresponding to two ᴅ-glucopyranoses (δC 62.5, 70.0, 77.5, 77.9, 85.0, 103.2 and δC 61.5, 69.3, 76.7, 82.9, 85.5, 104.5). The signal at δC 85.0 was assigned to C-2′ based on the H2BC correlation with the anomeric proton at δH 4.57 (d, J = 7.8 Hz, 1H, H-1′), which corresponded to the carbon at δC 103.2 (C-1′). Furthermore, the 1D-TOCSY experiment involving irradiation at δH 2.52 (br d, J = 9.2 Hz, 1H, H-5′′) resulted in the excitement of resonances at δH 3.32 (m, 3H, H-2′′, 3′′, 4′′, overlapping) and 3.50 (br s, 2H, H2-6′′) as well as an anomeric proton resonance at δH 4.30 (d, J = 7.3 Hz, 1H, H-1′′), which corresponded to the carbon at δC 104.5 (C-1′′). Based on the H2BC correlations of H-1′′/C-2′′ and H-5′′/C-4′′, the signals at δC 82.9 and 69.3 were assigned to C-2′′ and C-4′′, respectively, and that at δC 85.5 was assigned to C-3′′. The HSQC, 1D-TOCSY, and HSQC-TOCSY spectra also revealed a series of carbon signals corresponding to ʟ-rhamnose at δC 17.9, 70.5, 72.0, 72.1, 73.7, and 103.3. The remaining five carbon signals [an anomeric methine at δC 111.9 (C-1′′′′), a methine at δC 77.5 (C-2′′′′), two methylenes at δC 64.8 (C-5′′′′) and 74.5 (C-4′′′′), and a nonprotonated carbon at δC 79.3 (C-3′′′′)] were characteristic of apiofuranose. The presence of apiofuranose was also supported by the HMBC correlations of H-1′′′′/C-3′′′′, C-4′′′′ and H2-4′′′′/C-5′′′′, C-2′′′′ as well as the H2BC correlation of H-1′′′′/C-2′′′′. The linkages in the sugar moiety were determined based on the HMBC correlations of H-1′/C-3, H-1′′/C-2′, H-1′′′/C-3′′′, and H-1′′′′/C-2′′ and the SSCCs of the anomeric protons.
Table 2: 1H and 13C NMR data for the sugar moieties of 1, 2, and 4.a
no. | 1 | 2 | 4 | |||||
δC | δH (mult, J) | δC | δH (mult, J) | δC | δH (mult, J) | |||
Glc | ||||||||
1′ | 103.2 | 4.57 (d, 7.8) | 102.8 | 4.47 (d, 7.8) | 94.0 | 5.78 (d, 7.8) | ||
2′ | 85.0 | 3.38 (t, 6.0) | 85.2 | 3.27 (t, 8.7) | 84.8 | 3.31 (t, 8.7) | ||
3′ | 77.5b | 3.57 (t, 8.7) | 77.6c | 3.53 (t, 9.2) | 77.6 | 3.58 (t, 9.2) | ||
4′ | 70.0 | 3.54 (t, 9.2) | 70.1 | 3.44 (t, 9.6) | 70.4 | 3.66 (t, 9.6) | ||
5′ | 77.9b | 3.31 (m) | 78.0 | 3.33 (m) | 79.3 | 3.43 (m) | ||
6′ | 62.5 | 3.73 (dd, 5.0, 11.4) | 62.5 | 3.71 (dd, 5.6, 11.9) | 62.2 | 3.83 (m) | ||
3.85 (dd, 2.3, 11.9) | 3.89 (br d, 11.9) | 3.93 (br d, 11.2) | ||||||
Glc | ||||||||
1′′ | 104.5 | 4.30 (d, 7.3) | 104.7 | 4.26 (d, 6.9) | 107.0 | 3.79 (d, 7.8) | ||
2′′ | 82.9 | 3.32 (m) | 83.0 | 3.35 (m) | 75.9 | 3.07 (t, 9.2) | ||
3′′ | 85.5 | 3.32 (m) | 85.5 | 3.35 (m) | 77.8 | 3.25 (t, 9.6) | ||
4′′ | 69.3 | 3.32 (m) | 69.2 | 3.32 (m) | 70.0d | 3.18 (t, 9.2) | ||
5′′ | 76.7 | 2.52 (br d, 9.2) | 76.6 | 2.44 (br d, 8.7) | 77.1 | 2.41 (br d, 9.2) | ||
6′′ | 61.5 | 3.50 (br s) | 61.4 | 3.47 (br t, 2.7) | 61.4 | 3.42 (br d, 12.3) | ||
3.49 (dd, 2.7, 12.3) | ||||||||
Rha | ||||||||
1′′′ | 103.3 | 4.99 (d, 0.9) | 103.3 | 4.98 (d, 1.4) | ||||
2′′′ | 72.0e | 4.12 (dd, 1.8, 3.2) | 72.0f | 4.11 (dd, 1.4, 3.2) | ||||
3′′′ | 72.1e | 3.67 (dd, 3.2, 9.2) | 72.1f | 3.67 (dd, 3.2, 9.2) | ||||
4′′′ | 73.7 | 3.41 (d, 9.6) | 73.7 | 3.41 (t, 9.6) | ||||
5′′′ | 70.5 | 3.91 (m) | 70.5 | 3.94 (m) | ||||
6′′′ | 17.9 | 1.26 (d, 6.4) | 17.9 | 1.26 (d, 6.4) | ||||
Api | ||||||||
1′′′′ | 111.9 | 5.20 (d, 4.1) | 112.0 | 5.20 (d, 4.1) | ||||
2′′′′ | 77.5b | 3.90 (d, 4.1) | 77.5c | 3.89 (d, 4.6) | ||||
3′′′′ | 79.3 | 79.3 | ||||||
4′′′′ | 74.5 | 3.75 (d, 9.6) | 74.5 | 3.75 (d, 9.6) | ||||
4.15 (d, 9.6) | 4.15 (d, 9.6) | |||||||
5′′′′ | 64.8 | 3.55 (d, 11.9) | 64.8 | 3.55 (d, 11.7) | ||||
3.60 (d, 11.9) | 4.59 (d, 11.7) |
a1H and 13C NMR data were obtained at 400 and 100 MHz, respectively. All spectra were measured in CD3OD. Overlapped signals were assigned based on the DQF-COSY, HSQC, HMBC, 1D-TOCSY, H2BC, and HSQC-TOCSY. b,c,e,fThese assignments are interchangeable. dOverlapping signals with C-11 of the aglycone moiety.
The sugars contained in 1 and their absolute configurations were confirmed by analyzing the monosaccharide mixture obtained by acid hydrolysis of 1 using the method developed by Tanaka et al. [16], in which the hydrolysates are derivatized with ʟ-cysteine methyl ester and o-tolyl isothiocyanate followed by HPLC analysis. For compound 1, peaks were observed at retention times of 13.96, 20.83, and 22.16 min. The peaks at 13.96 and 22.16 min were coincident with those of the ᴅ-glucose and ʟ-rhamnose derivatives, respectively. Although the peak at 20.83 min was assumed to be attributable to apiofuranose, we were unable to obtain any standard for apiofuranose. In the reported monosaccharide identification method, the retention times of the ᴅ-glucose, ʟ-rhamnose, ᴅ-apiose, and ʟ-apiose derivatives were 17.48, 29.47, 28.57, and 15.69 min, respectively, with the ᴅ-apiose derivative having a longer retention time than the ʟ-apiose derivative [16]. Therefore, considering the retention times of the ᴅ-glucose (13.96 min) and ʟ-rhamnose (22.16 min) derivatives in this study, it is reasonable to assign the peak at 20.83 min to the ᴅ-apiose derivative. Therefore, 1 was identified as breynogenin-α-S-oxide 3-O-β-ᴅ-apiofuranosyl-(1→2)-[α-ʟ-rhamnopyranosyl-(1→3)]-β-ᴅ-glucopyranosyl-(1→2)-β-ᴅ-glucopyranoside.
Epibreynin J (2) was also isolated as an amorphous, colorless powder. Because the sodium adduct ion peak at m/z 1107.3178 in the HRESIMS spectrum gave the same molecular formula as that of 1 (C45H64O28SNa, calcd 1107.3197), compounds 1 and 2 were determined to be isomers. The 1D and 2D NMR spectroscopic data indicated that the aglycone of 2 also consisted of a breynogenin-S-oxide moiety. However, a comparison of the 1H and 13C NMR data for the aglycones of 1 and 2 revealed markedly different tetrahydrothiophene signals [for 2, δC 61.7 (C-2), 87.4 (C-3), 39.9 (C-4), 62.3 (C-17)] (Table 1). According to previous literature [2], these differences indicate that the sulfoxide moieties in the aglycone of 1 and 2 are isomers. The remaining NMR resonances (Table 2) and 2D NMR spectroscopic data (Figure 2) showed that the glycosyl group of 2 was the same as that of 1. This assignment was further supported by HPLC-based monosaccharide identification, which revealed peaks at retention times of 13.97 (ᴅ-glucose), 20.84 (ᴅ-apiose), and 22.17 (ʟ-rhamnose) min. Hence, 2 was identified as breynogenin-β-S-oxide 3-O-β-ᴅ-apiofuranosyl-(1→2)-[α-ʟ-rhamnopyranosyl-(1→3)]-β-ᴅ-glucoptranosyl-(1→2)-β-ᴅ-glucopyranoside.
Furthermore, we investigated the absolute configurations of the aglycones of 1 and 2 as well as those of breynin B (6) and epibreynin B (7) by comparing their experimental electronic CD (ECD) curves with the calculated ECD curves of molecular models 1′ and 2′, in which the glucosyl units were replaced with 2-hydroxytetrahydropyran to reduce computational costs (Figure 3a). The calculated ECD curve for 1′ agreed well with the experimental ECD spectra of 1 and 6, indicating that the aglycones of these compounds had an absolute configuration of 1R,3R,4R,6S,7R,9S,11S,12R,16S,17S (Figure 3b). Similarly, the absolute configurations of compounds 2 and 7 were determined to be 1S,3R,4R,6S,7R,9S,11S,12R,16S,17S (Figure 3c).
Probreynogenin (3) was isolated as an amorphous, colorless solid. The molecular formula of 3 was determined to be C23H27NO11S based on the sodium adduct ion peak at m/z 548.1197 [M + Na]+ (calcd 548.1197) observed by HRESIMS. The 1H NMR spectrum (Table 1) showed no sugar moiety signals, but the characteristic signals of a methyl group [δH 0.88 (d, J = 6.9 Hz, 3H, H3-18)] and a p-hydroxybenzoate moiety [δH 7.99 (d, J = 8.7 Hz, 2H, H-21, 25), 6.90 (d, J = 8.7 Hz, 2H, H-22, 24)] were detected. The 13C NMR spectrum (Table 1) exhibited signals corresponding to a spiro-carbon at δC 100.6 (C-9) and a ketone carbon at δC 213.3 (C-8). The HMBC correlations of H-10β/C-8, C-9, C-11, C-12; H-11/C-9, C-13; H2-13/C-9; H-16/C-7, C-8; and H3-18/C-11, C-12, C-13 and the connectivity confirmed by DQF-COSY indicated that 3 also contained a 1,6-dioxaspiro[4,5]decane moiety with a methyl group, as in compounds 1 and 2 (Figure 4). The p-hydroxybenzoylcarbonyl group was connected to C-11, as evidenced by the HMBC correlation of H-11/C-19. The DQF-COSY spectrum revealed a C-16/C-17/C-3/C-4/C-5 linkage, which was confirmed by the HMBC correlations of H-5/C-3, H-16/C-3, and H-17/C-4. The linkage between C-6 and C-7 was supported by the HMBC correlations of H-5/C-6 and H-16/C-5. Furthermore, the presence of a carbonyl group was indicated by the HMBC correlations of both H-5 and H-17 with a carbonyl carbon (δC 177.1). Thus, the structure of compound 3 was highly similar to that of phyllaemblic acid (5), which was previously isolated from Phyllanthus emblica and Glochidion coccineum [9,10] as well as from B. disticha in this study. The major structural difference between these compounds was the substituent at the C-17 position. The molecular weight of 3 was 89 mass units larger than that of 5, indicating that the unsubstituted C-17 in compound 5 was replaced with C2H4NOS. Based on the presences of the two carbons as a methylene carbon [δH 3.32 and 3.44 (d, J = 15.6 Hz, each 1H, H2-2); δC 37.3 (C-2)] and a carbonyl carbon [δC 175.0 (C-3)] as well as the HMBC correlations of H2-2 with C-3 and C-17, this substituent was identified as a (2-amino-2-oxoethyl)thio group. This substituent has been reported in several alkaloids isolated from plants in the Aristolochiaceae family [17,18]. Compound 3 had a β orientation for the sulfur-containing substituent at C-17 and the same relative configuration as 5 otherwise, as supported by the SSCC and NOE observed in the 1H NMR, NOESY, and J-resolved spectra. As the computed and experimental ECD curves of 3 were in good agreement, the absolute configuration of compound 3 was established as 4R,6S,7R,9S,11S,12R,16S,17S (Figure 5).
Probreynin I (4) was isolated as an amorphous, colorless solid. The sodium adduct ion peak at m/z 872.2241 in the HRESIMS spectrum indicated a molecular formula of C35H47NO21SNa (calcd 872.2253). A comparison with the molecular formula and 1H and 13C NMR spectroscopic data of 3 suggested that compound 4 contained two additional hexopyranose units (Table 1 and Table 2). The 1D-TOCSY spectrum showed two proton sequences corresponding to these hexopyranose units and the SSCCs indicated that both were glucopyranose. The characteristic 1H and 13C NMR signals of one anomeric proton [δH 5.78 (d, J = 7.8 Hz, 1H, H-1′); δC 94.0 (C-1′)] implied that compound 4 was a β-glycosyl ester. The HMBC correlation of H-1′ with a carbonyl carbon [δC 174.7 (C-3)] revealed that esterification occurred at C-3 with a glucopyranose moiety at the anomeric position (Figure 4). A β-1,3-glucosyl linkage between the two glucopyranose moieties was confirmed by the HMBC correlation of H-1′′/C-2′ and the H2BC correlation of H-1′/C-2′, giving the relative structure of 4 shown in Figure 1. Although 1D NMR and HRESIMS data for probreynin I (4) were reported in a Chinese patent in 2019 [13], no structural analysis based on 2D NMR spectroscopy has previously been described.
He et al. reported that epibreynin D, which bears the same aglycone moiety as compounds 2 and 7, exhibits anti-inflammatory effects in mice and rat models [12]. To investigate the anti-inflammatory effects of the sulfur-containing compounds isolated in this study, we investigated the lipopolysaccharide (LPS)-induced production of proinflammatory cytokines – interleukin (IL)-1β, IL-6, and TNF-α – in RAW 264.7 murine macrophage cells by quantitative real-time polymerase chain reaction (qRT-PCR) analysis. The sulfur-containing spiroketals 1–3, 6, and 7 were tested, whereas compound 4 was not because of its lower yield. The LPS-induced increases in IL-1β and IL-6 mRNA levels were significantly inhibited by compounds 1, 2, 6, and 7 but enhanced by compound 3 (Figure 6a and 6b). In addition, the LPS-induced increase in TNF-α mRNA levels was not affected by any of the tested compounds (Figure 6c).
Further investigations of anti-inflammatory activity were focused on compound 7, which showed the strongest inhibitory effect, although not significantly. The 3-(4,5-dimethylthiazol-2-yl)-2,5-diphenyltetrazolium bromide (MTT) assay revealed that compound 7 was cytotoxic to RAW 264.7 cells at concentrations above 25 μM (Figure 6d). Furthermore, 7 suppressed the LPS-induced increases in IL-1β and IL-6 transcriptional levels in a concentration-dependent manner from 1 or 2.5 μM (Figure 6e). Thus, while cytotoxicity was likely involved in the suppression of mRNA levels at high concentrations (>25 μM) of compound 7, anti-inflammatory effects occurred at lower concentrations without cytotoxicity. The production of IL-1β and IL-6 was also evaluated by an enzyme-linked immunosorbent assay (ELISA) using culture supernatants. The LPS-stimulated increase in IL-1β and IL-6 production was suppressed by compound 7 at a concentration of 10 μM (Figure 6f and 6g). Thus, compound 7 inhibited LPS-stimulated IL-1β and IL-6 mRNA and protein expression in RAW 264.7 cells. Although confirmed only at the mRNA level, 1, 2, and 6 likely exhibit similar behavior, suggesting that the steric configuration of the sulfoxide group and the structure of the sugar chain may not influence the anti-inflammatory effect. In contrast, compound 3 did not show anti-inflammatory activity, suggesting that a thiophene ring or a sulfoxide group in breynins is involved in the onset of anti-inflammatory action.
Conclusion
The biosynthesis of breynins with novel skeletons remains poorly understood, especially with respect to the sulfur source. In this study, we isolated a new aglycone, probreynogenin (3), together with a known sesquiterpenoid, phyllaemblic acid (5), suggesting that breynin formation may involve the attachment of a mercaptoacetamide to 5, followed by cyclization. However, to the best of our knowledge, the origin of mercaptoacetamide has not been reported and further biosynthetic exploration is needed. We also isolated two new sulfur-containing spiroketals (1 and 2) with a tetrasaccharide moiety. For terpenoid glycosides, the 1H NMR spectrum becomes more complex as the number of sugar residues and their lengths increase, which complicates 2D NMR analysis. In such cases, commonly used TOCSY measurements can be supplemented by H2BC and HSQC-TOCSY correlations to analyze C–C linkages. Further studies are underway to investigate the mechanism of inflammation suppression by breynins and epibreynins.
Experimental
General experimental procedures
Optical rotation values were determined using a JASCO P-1020 polarimeter. UV spectra were recorded using a Hitachi U-2900 spectrometer. ECD spectra were acquired with a JASCO J-820 spectropolarimeter and IR spectra were recorded using a Shimadzu FTIR-8400S spectrophotometer. NMR spectra were acquired with a JEOL JNM-ECZ 400S spectrometer with tetramethylsilane as an internal standard. ESI–MS data were obtained using an Agilent 6230 LC/TOF mass spectrometer. HPLC was performed on a Hitachi HPLC system equipped with an L-2130 pump, an L-2200 autosampler, an L-2300 column oven, and an L-2455 diode array detector. Silica gel AP-300 (Toyota Kako), Sephadex LH-20 (GE Healthcare), and Cosmosil 75C18-OPN (Nacalai Tesque) were used for column chromatography (CC). Silica gel 60 F254 and RP-18 F254S (Merck) were used for TLC analysis.
Plant material
B. disticha was cultivated in the greenhouse of Setsunan University medicinal plant garden (Osaka, Japan) in September 2014. Taxonomic identification was performed by an expert botanist, Ms. Hiroko Murata (Setsunan University, retired). A voucher specimen (GPU-0812) has been deposited at the Gifu Pharmaceutical University for future reference.
Extraction and isolation
The dried roots (767 g) of B. disticha were extracted with MeOH (5 L × 3 times) at room temperature, and the solution was evaporated in vacuo to afford a MeOH extract (47.2 g). The MeOH extract was partitioned three times with 1.6 L of ethyl acetate and water 1:1 (v/v), and the water-soluble fraction was further partitioned three times with 800 mL of n-butanol. The ethyl acetate and n-butanol solutions were concentrated in vacuo to yield the ethyl acetate fraction (11.8 g) and n-butanol fraction (7.4 g), respectively. The ethyl acetate fraction was separated by silica gel CC with CHCl3/MeOH (stepwise gradient of 100:1, 50:1, 30:1, 20:1, 15:1, 10:1, 8:1, and 0:1, v/v) as the eluent. The fractions were pooled by TLC analysis to yield seven combined fractions (Frs. E1–E7). Frs. E5 and E6 were further separated on a Sephadex LH-20 column eluted with MeOH to obtain compounds 5 (15.2 mg) and 3 (13.3 mg), respectively. The n-butanol fraction was separated on a Sephadex LH-20 column eluted with MeOH. The fractions were pooled by TLC analysis to yield four combined fractions (Frs. B1–B4). Fr. B2 was further separated on an ODS column eluted with MeOH/H2O (stepwise gradient of 2:3, 1:1, 3:2, and 1:0, v/v) to yield four combined subfractions. The second subfraction was separated by silica gel CC with ethyl acetate/MeOH 2:1 (v/v) to obtain compounds 1 (95.8 mg) and 6 (109.7 mg). The third subfraction was subjected to silica gel CC with ethyl acetate/MeOH 2:1 (v/v) to yield compounds 2 (79.0 mg) and 7 (44.1 mg). The fourth subfraction was purified by silica gel CC with ethyl acetate/MeOH 10:1 (v/v) to obtain compound 4 (1.2 mg).
Breynin J (1): amorphous, colorless powder. [α]D22 −8.0 (c 0.05, MeOH); UV λmax (MeOH) nm (log ε): 257 (4.09); IR (KBr) cm−1: 3414, 2969, 2936, 2888, 1782, 1695, 1609, 1516, 1456, 1395, 1348, 1314, 1279, 1167, 1117, 1078, 1036, 854, 831, 773, 741, 700, 667, 619, 550, 511, 471; 1H and 13C NMR data, see Table 1 and Table 2. HRESIMS (m/z): [M + Na]+ calcd for C45H64O28SNa, 1107.3197; found, 1107.3177 .
Epibreynin J (2): amorphous, colorless powder. [α]D22 −45.2 (c 0.05, MeOH); UV λmax (MeOH) nm (log ε): 257 (4.08); IR (KBr) cm−1: 3404, 2969, 2936, 2888, 1734, 1694, 1609, 1516, 1346, 1314, 1279, 1167, 1119, 1078, 1038, 1005, 854, 831, 773, 698, 667, 619, 586, 548, 509, 471; 1H and 13C NMR data, see Table 1 and Table 2; HRESIMS (m/z): [M + Na]+ calcd for C45H64O28SNa, 1107.3197; found, 1107.3178 .
Probreynogenin (3): amorphous, colorless solid. [α]D22 +50.8 (c 0.05, MeOH); UV λmax (MeOH) nm (log ε): 257 (4.10); IR (KBr) cm–1: 3430, 2969, 2936, 2889, 1780, 1674, 1609, 1593, 1514, 1437, 1391, 1360, 1344, 1312, 1281, 1167, 1117, 1084, 1060, 1044, 999, 980, 853, 773; 1H and 13C NMR data, see Table 1. HRESIMS (m/z): [M + Na]+ calcd for C23H27NO11SNa, 548.1197; found, 548.1197 .
Probreynin I (4): amorphous, colorless solid. [α]D22 +21.6 (c 0.05, MeOH); UV λmax (MeOH) nm (log ε): 257 (3.65); IR (KBr) cm–1: 3404, 2965, 2936, 2888, 1780, 1749, 1670, 1609, 1514, 1456, 1387, 1373, 1362, 1341, 1314, 1279, 1167, 1117, 1078, 773, 617, 584, 550; 1H and 13C NMR data, see Table 1 and Table 2; HRESIMS (m/z): [M + Na]+ calcd for C35H47NO21SNa, 872.2253; found, 872.2241.
Identification of sugars in 1 and 2
Compound 1 (5 mg) was dissolved in 0.5 M hydrochloric acid in a glass centrifuge tube and heated at 95 °C for 2 h. The solution was neutralized with 0.5 M NaOH and concentrated in vacuo. To the residue was added a solution of ʟ-cysteine methyl ester hydrochloride (2 mg) in pyridine (200 μL), and the mixture was stirred at 65 °C for 1 h. Then, a solution of o-tolyl isothiocyanate (2.2 μL) in pyridine (200 μL) was added and the resulting mixture was stirred at 65 °C for 1 h. The final mixture was filtered and analyzed by HPLC without dilution. HPLC separation was performed on a 150 × 4.6 mm i.d. CAPCELL PAK C18 UG120 column (Osaka Soda) at 35 °C with isocratic elution using 20% CH3CN in 50 mM H3PO4 for 30 min and subsequent column washing with 90% CH3CN at a flow rate 0.8 mL/min. Detection at 250 nm was performed using a photodiode array detector. Compounds 2, 6, and 7 were derivatized and analyzed in a similar manner. Furthermore, derivatives of authentic sugars were analyzed, and peaks were observed at 8.34 (ᴅ-mannose), 12.17 (ᴅ-galactose), 12.74 (ʟ-glucose), 13.96 (ᴅ-glucose), 15.18 (ʟ-arabinose), 16.20 (ᴅ-arabinose), and 22.14 (ʟ-rhamnose) min.
Computational method
Conformers of 1′, 2′, and 3 were generated using CONFLEX 8 with the MMFF94s force field [19] and a search limit of 5 kcal/mol, respectively. Similar conformers were excluded, yielding 9 conformers for 1′, 10 conformers for 2′, and 24 conformers for 3. The geometry of each conformer was optimized using DFT calculations at the B3LYP/6-31G(d) level of theory [20,21] with the conductor-like polarizable continuum model (CPCM) solvent model (MeOH) and Gibbs free energy was calculated subsequent frequency calculations. Time-dependent (TD)-DFT calculations at the B3LYP/6-31+G(d,p) level with CPCM solvent model (MeOH) [22] were performed for the optimized conformers. The resulting ECD spectra calculated for each conformer were averaged using Boltzmann populations evaluated at 300 K from Gibbs free energy calculated from the frequency calculations.
Cell culture
RAW 264.7 cells were maintained in Dulbecco’s modified Eagle’s medium (DMEM) supplemented with 10% fetal bovine serum (FBS), 50 U/mL penicillin, and 50 μg/mL streptomycin at 37 °C in a humidified 5% CO2 atmosphere. Test samples (compounds 1–3, 6, and 7) were prepared to appropriate concentrations by dissolving in DMSO and diluting 1000-fold in medium. RAW 264.7 cells were preincubated with fresh medium containing test samples or vehicle (DMSO) for 24 h. After preincubation, LPS was added at a final concentration of 50 ng/mL.
qRT-PCR analysis
Total RNA was extracted using RNAiso Plus (Takara Bio) after 2 h of LPS treatment. cDNA was obtained by reverse transcription from 0.3 µg of total RNA using the ReverTra Ace RT-qPCR Master Mix with gDNA remover (Toyobo). qRT-PCR analysis was performed using a StepOnePlus real-time PCR system (Thermo Fisher Scientific) with the Thunderbird SYBR qPCR Mix. The relative concentration of each sample was normalized to the β-actin mRNA level. The relative mRNA expression levels of the target genes were analyzed using the ΔΔCt method.
MTT assay
To evaluate cell viability, RAW 264.7 cells were seeded into 96-well plates at a density of 5 × 104 cells/well 24 hours before adding samples. The cells were treated with compound 7 at concentrations 0.25, 1, 2.5, 10, 25, and 50 µM for 24 h and then 0.2 mg/mL MTT solution was added after incubating for 3 h at 37 °C in a humidified 5% CO2 atmosphere, the culture supernatants were removed. The resulting dark blue crystals were dissolved in dimethyl sulfoxide, and the absorbance of the obtained solution was measured at 492 nm.
ELISA
The concentrations of IL-1β and IL-6 in the culture medium after 12 h of LPS treatment were measured using Quantikine ELISA kits for mouse IL-1β and IL-6 (R&D Systems) according to the manufacturer’s instructions.
Statistical analysis
All experiments were performed in triplicate or quadruplicate. Statistical analyses were performed using GraphPad Prism, version 6.0 and data are presented as mean ± standard deviation. An unpaired two-tailed Student’s t-test was used for comparisons between two groups. Dunnett’s test was used for multiple comparisons. P < 0.05 was considered statistically significant.
References
-
Smith, A. B., III; Keenan, T. P.; Gallagher, R. T.; Furst, G. T.; Dormer, P. G. J. Org. Chem. 1992, 57, 5115–5120. doi:10.1021/jo00045a022
Return to citation in text: [1] -
Meng, D.; Chen, W.; Zhao, W. J. Nat. Prod. 2007, 70, 824–829. doi:10.1021/np0606300
Return to citation in text: [1] [2] [3] [4] [5] [6] -
Meng, D.-H.; Wu, J.; Wang, L.-Y.; Zhao, W.-M. J. Asian Nat. Prod. Res. 2010, 12, 535–541. doi:10.1080/10286021003745452
Return to citation in text: [1] [2] -
Peng, W.-W.; Wang, Z.-Q.; Ji, M.-Y.; Liao, Z.-L.; Liu, Z.-Q.; Wu, P. Phytochem. Lett. 2017, 22, 1–5. doi:10.1016/j.phytol.2017.08.003
Return to citation in text: [1] -
Umeokoli, B. O.; Onyegbule, F. A.; Okoye, F. B. C.; Wang, H.; Kalscheuer, R.; Müller, W. E. G.; Hartmann, R.; Liu, Z.; Proksch, P. Fitoterapia 2017, 122, 16–19. doi:10.1016/j.fitote.2017.08.009
Return to citation in text: [1] [2] -
Saadullah, M.; Asif, M.; Farid, A.; Naseem, F.; Rashid, S. A.; Ghazanfar, S.; Muzammal, M.; Ahmad, S.; Bin Jardan, Y. A.; Alshaya, H.; Saleem, M. H.; Ali, S.; Adetunji, C. O.; Arif, S. Molecules 2022, 27, 2596. doi:10.3390/molecules27082596
Return to citation in text: [1] -
Lv, J.-J.; Wang, Y.-F.; Zhang, J.-M.; Yu, S.; Wang, D.; Zhu, H.-T.; Cheng, R.-R.; Yang, C.-R.; Xu, M.; Zhang, Y.-J. Org. Biomol. Chem. 2014, 12, 8764–8774. doi:10.1039/c4ob01196a
Return to citation in text: [1] -
Lv, J.-J.; Yu, S.; Xin, Y.; Cheng, R.-R.; Zhu, H.-T.; Wang, D.; Yang, C.-R.; Xu, M.; Zhang, Y.-J. Phytochemistry 2015, 117, 123–134. doi:10.1016/j.phytochem.2015.06.001
Return to citation in text: [1] -
Xiao, H.-T.; Hao, X.-Y.; Yang, X.-W.; Wang, Y.-H.; Lu, Y.; Zhang, Y.; Gao, S.; He, H.-P.; Hao, X.-J. Helv. Chim. Acta 2007, 90, 164–170. doi:10.1002/hlca.200790011
Return to citation in text: [1] [2] -
Zhang, Y.-J.; Tanaka, T.; Iwamoto, Y.; Yang, C.-R.; Kouno, I. Tetrahedron Lett. 2000, 41, 1781–1784. doi:10.1016/s0040-4039(00)00015-0
Return to citation in text: [1] [2] [3] [4] -
Li, B.; Qiu, H.; Ma, J. S.; Zhu, H.; Gilbert, M. G.; Esser, H. J.; Dressler, S.; Hoffmann, P.; Gillespie, L. J.; Vorontsova, M.; McPherson, G. D. Euphorbiaceae. Flora of China, 2008, 11, 163–314. http://www.efloras.org/florataxon.aspx?flora_id=2&taxon_id=10327. (Accessed July 27, 2023).
Return to citation in text: [1] -
He, X.-L.; Lv, J.-J.; Wang, X.; Zhang, Q.; Zhang, B.; Cao, K.; Liu, L.-L.; Xu, Y. J. Ethnopharmacol. 2019, 239, 111894. doi:10.1016/j.jep.2019.111894
Return to citation in text: [1] [2] -
Lv, J. J.; He, X. L.; Guo, S. C.; He, D. X. Sulfur-containing spiroketal sesquiterpene compound utilized for preparing anti-inflammatory and hypolipidemic drugs. Chin. Patent CN110256511, July 30, 2019.
Return to citation in text: [1] [2] [3] -
de Beer, T.; van Zuylen, C. W. E. M.; Hård, K.; Boelens, R.; Kaptein, R.; Kamerling, J. P.; Vliegenthart, J. F. G. FEBS Lett. 1994, 348, 1–6. doi:10.1016/0014-5793(94)00547-8
Return to citation in text: [1] -
Nyberg, N. T.; Duus, J. Ø.; Sørensen, O. W. Magn. Reson. Chem. 2005, 43, 971–974. doi:10.1002/mrc.1698
Return to citation in text: [1] -
Tanaka, T.; Nakashima, T.; Ueda, T.; Tomii, K.; Kouno, I. Chem. Pharm. Bull. 2007, 55, 899–901. doi:10.1248/cpb.55.899
Return to citation in text: [1] [2] -
Rios, M. Y.; Navarro, V.; Ramírez-Cisneros, M. Á.; Salazar-Rios, E. J. Nat. Prod. 2017, 80, 3112–3119. doi:10.1021/acs.jnatprod.7b00226
Return to citation in text: [1] -
Ohta, S.; Oshimo, S.; Ohta, E.; Nehira, T.; Ômura, H.; Uy, M. M.; Ishihara, Y. J. Nat. Prod. 2020, 83, 3050–3057. doi:10.1021/acs.jnatprod.0c00574
Return to citation in text: [1] -
Halgren, T. A. J. Comput. Chem. 1999, 20, 720–729. doi:10.1002/(sici)1096-987x(199905)20:7<720::aid-jcc7>3.0.co;2-x
Return to citation in text: [1] -
Becke, A. D. J. Chem. Phys. 1993, 98, 5648–5652. doi:10.1063/1.464913
Return to citation in text: [1] -
Ditchfield, R.; Hehre, W. J.; Pople, J. A. J. Chem. Phys. 1971, 54, 724–728. doi:10.1063/1.1674902
Return to citation in text: [1] -
Barone, V.; Cossi, M. J. Phys. Chem. A 1998, 102, 1995–2001. doi:10.1021/jp9716997
Return to citation in text: [1]
1. | Smith, A. B., III; Keenan, T. P.; Gallagher, R. T.; Furst, G. T.; Dormer, P. G. J. Org. Chem. 1992, 57, 5115–5120. doi:10.1021/jo00045a022 |
2. | Meng, D.; Chen, W.; Zhao, W. J. Nat. Prod. 2007, 70, 824–829. doi:10.1021/np0606300 |
3. | Meng, D.-H.; Wu, J.; Wang, L.-Y.; Zhao, W.-M. J. Asian Nat. Prod. Res. 2010, 12, 535–541. doi:10.1080/10286021003745452 |
7. | Lv, J.-J.; Wang, Y.-F.; Zhang, J.-M.; Yu, S.; Wang, D.; Zhu, H.-T.; Cheng, R.-R.; Yang, C.-R.; Xu, M.; Zhang, Y.-J. Org. Biomol. Chem. 2014, 12, 8764–8774. doi:10.1039/c4ob01196a |
8. | Lv, J.-J.; Yu, S.; Xin, Y.; Cheng, R.-R.; Zhu, H.-T.; Wang, D.; Yang, C.-R.; Xu, M.; Zhang, Y.-J. Phytochemistry 2015, 117, 123–134. doi:10.1016/j.phytochem.2015.06.001 |
9. | Xiao, H.-T.; Hao, X.-Y.; Yang, X.-W.; Wang, Y.-H.; Lu, Y.; Zhang, Y.; Gao, S.; He, H.-P.; Hao, X.-J. Helv. Chim. Acta 2007, 90, 164–170. doi:10.1002/hlca.200790011 |
10. | Zhang, Y.-J.; Tanaka, T.; Iwamoto, Y.; Yang, C.-R.; Kouno, I. Tetrahedron Lett. 2000, 41, 1781–1784. doi:10.1016/s0040-4039(00)00015-0 |
14. | de Beer, T.; van Zuylen, C. W. E. M.; Hård, K.; Boelens, R.; Kaptein, R.; Kamerling, J. P.; Vliegenthart, J. F. G. FEBS Lett. 1994, 348, 1–6. doi:10.1016/0014-5793(94)00547-8 |
15. | Nyberg, N. T.; Duus, J. Ø.; Sørensen, O. W. Magn. Reson. Chem. 2005, 43, 971–974. doi:10.1002/mrc.1698 |
5. | Umeokoli, B. O.; Onyegbule, F. A.; Okoye, F. B. C.; Wang, H.; Kalscheuer, R.; Müller, W. E. G.; Hartmann, R.; Liu, Z.; Proksch, P. Fitoterapia 2017, 122, 16–19. doi:10.1016/j.fitote.2017.08.009 |
6. | Saadullah, M.; Asif, M.; Farid, A.; Naseem, F.; Rashid, S. A.; Ghazanfar, S.; Muzammal, M.; Ahmad, S.; Bin Jardan, Y. A.; Alshaya, H.; Saleem, M. H.; Ali, S.; Adetunji, C. O.; Arif, S. Molecules 2022, 27, 2596. doi:10.3390/molecules27082596 |
16. | Tanaka, T.; Nakashima, T.; Ueda, T.; Tomii, K.; Kouno, I. Chem. Pharm. Bull. 2007, 55, 899–901. doi:10.1248/cpb.55.899 |
5. | Umeokoli, B. O.; Onyegbule, F. A.; Okoye, F. B. C.; Wang, H.; Kalscheuer, R.; Müller, W. E. G.; Hartmann, R.; Liu, Z.; Proksch, P. Fitoterapia 2017, 122, 16–19. doi:10.1016/j.fitote.2017.08.009 |
2. | Meng, D.; Chen, W.; Zhao, W. J. Nat. Prod. 2007, 70, 824–829. doi:10.1021/np0606300 |
3. | Meng, D.-H.; Wu, J.; Wang, L.-Y.; Zhao, W.-M. J. Asian Nat. Prod. Res. 2010, 12, 535–541. doi:10.1080/10286021003745452 |
10. | Zhang, Y.-J.; Tanaka, T.; Iwamoto, Y.; Yang, C.-R.; Kouno, I. Tetrahedron Lett. 2000, 41, 1781–1784. doi:10.1016/s0040-4039(00)00015-0 |
4. | Peng, W.-W.; Wang, Z.-Q.; Ji, M.-Y.; Liao, Z.-L.; Liu, Z.-Q.; Wu, P. Phytochem. Lett. 2017, 22, 1–5. doi:10.1016/j.phytol.2017.08.003 |
2. | Meng, D.; Chen, W.; Zhao, W. J. Nat. Prod. 2007, 70, 824–829. doi:10.1021/np0606300 |
10. | Zhang, Y.-J.; Tanaka, T.; Iwamoto, Y.; Yang, C.-R.; Kouno, I. Tetrahedron Lett. 2000, 41, 1781–1784. doi:10.1016/s0040-4039(00)00015-0 |
2. | Meng, D.; Chen, W.; Zhao, W. J. Nat. Prod. 2007, 70, 824–829. doi:10.1021/np0606300 |
13. | Lv, J. J.; He, X. L.; Guo, S. C.; He, D. X. Sulfur-containing spiroketal sesquiterpene compound utilized for preparing anti-inflammatory and hypolipidemic drugs. Chin. Patent CN110256511, July 30, 2019. |
13. | Lv, J. J.; He, X. L.; Guo, S. C.; He, D. X. Sulfur-containing spiroketal sesquiterpene compound utilized for preparing anti-inflammatory and hypolipidemic drugs. Chin. Patent CN110256511, July 30, 2019. |
12. | He, X.-L.; Lv, J.-J.; Wang, X.; Zhang, Q.; Zhang, B.; Cao, K.; Liu, L.-L.; Xu, Y. J. Ethnopharmacol. 2019, 239, 111894. doi:10.1016/j.jep.2019.111894 |
11. | Li, B.; Qiu, H.; Ma, J. S.; Zhu, H.; Gilbert, M. G.; Esser, H. J.; Dressler, S.; Hoffmann, P.; Gillespie, L. J.; Vorontsova, M.; McPherson, G. D. Euphorbiaceae. Flora of China, 2008, 11, 163–314. http://www.efloras.org/florataxon.aspx?flora_id=2&taxon_id=10327. (Accessed July 27, 2023). |
2. | Meng, D.; Chen, W.; Zhao, W. J. Nat. Prod. 2007, 70, 824–829. doi:10.1021/np0606300 |
9. | Xiao, H.-T.; Hao, X.-Y.; Yang, X.-W.; Wang, Y.-H.; Lu, Y.; Zhang, Y.; Gao, S.; He, H.-P.; Hao, X.-J. Helv. Chim. Acta 2007, 90, 164–170. doi:10.1002/hlca.200790011 |
10. | Zhang, Y.-J.; Tanaka, T.; Iwamoto, Y.; Yang, C.-R.; Kouno, I. Tetrahedron Lett. 2000, 41, 1781–1784. doi:10.1016/s0040-4039(00)00015-0 |
16. | Tanaka, T.; Nakashima, T.; Ueda, T.; Tomii, K.; Kouno, I. Chem. Pharm. Bull. 2007, 55, 899–901. doi:10.1248/cpb.55.899 |
2. | Meng, D.; Chen, W.; Zhao, W. J. Nat. Prod. 2007, 70, 824–829. doi:10.1021/np0606300 |
20. | Becke, A. D. J. Chem. Phys. 1993, 98, 5648–5652. doi:10.1063/1.464913 |
21. | Ditchfield, R.; Hehre, W. J.; Pople, J. A. J. Chem. Phys. 1971, 54, 724–728. doi:10.1063/1.1674902 |
22. | Barone, V.; Cossi, M. J. Phys. Chem. A 1998, 102, 1995–2001. doi:10.1021/jp9716997 |
12. | He, X.-L.; Lv, J.-J.; Wang, X.; Zhang, Q.; Zhang, B.; Cao, K.; Liu, L.-L.; Xu, Y. J. Ethnopharmacol. 2019, 239, 111894. doi:10.1016/j.jep.2019.111894 |
19. | Halgren, T. A. J. Comput. Chem. 1999, 20, 720–729. doi:10.1002/(sici)1096-987x(199905)20:7<720::aid-jcc7>3.0.co;2-x |
17. | Rios, M. Y.; Navarro, V.; Ramírez-Cisneros, M. Á.; Salazar-Rios, E. J. Nat. Prod. 2017, 80, 3112–3119. doi:10.1021/acs.jnatprod.7b00226 |
18. | Ohta, S.; Oshimo, S.; Ohta, E.; Nehira, T.; Ômura, H.; Uy, M. M.; Ishihara, Y. J. Nat. Prod. 2020, 83, 3050–3057. doi:10.1021/acs.jnatprod.0c00574 |
13. | Lv, J. J.; He, X. L.; Guo, S. C.; He, D. X. Sulfur-containing spiroketal sesquiterpene compound utilized for preparing anti-inflammatory and hypolipidemic drugs. Chin. Patent CN110256511, July 30, 2019. |
© 2023 Nakashima et al.; licensee Beilstein-Institut.
This is an open access article licensed under the terms of the Beilstein-Institut Open Access License Agreement (https://www.beilstein-journals.org/bjoc/terms), which is identical to the Creative Commons Attribution 4.0 International License (https://creativecommons.org/licenses/by/4.0). The reuse of material under this license requires that the author(s), source and license are credited. Third-party material in this article could be subject to other licenses (typically indicated in the credit line), and in this case, users are required to obtain permission from the license holder to reuse the material.